Lawrence Plastic Injected Molded Products

Consolidated Container Company is one of the leading developers, manufacturers and marketers of rigid plastic containers in North America. It provides containers to consumer product and beverage firms. The company has more than 3,400 employees and over 70 manufacturing facilities across North America. It produces 7 billion packages annually and serves the dairy, water, personal care, agriculture and food sectors. The company offers custom and stock packaging options. It provides engineering, product development, material testing and program management services. Consolidated Container Company operates a nearly 40,000-square-foot facility, the Panella Center for Engineering & Development. It wholly owns Consolidated Container Capital. The company is a part of Consolidated Container Holdings.

International Plastics & Equipment is a manufacturer of tamper evident plastic closures. These closures are used in the bottling of non-carbonated beverages including bottled water, milk, fruit and sport drinks. IPEC also designs and fabricates capping equipment. IPEC's commitment to research and development has led to significant product innovations. These innovations include the tamper evident series of sport and flat closures presently used in the bottled water and juice markets. These closures are intended for the new generation of 'light finish' bottles that are being introduced as a low cost alternative to present containers being used in the non-carbonated markets. IPEC's innovation is also seen in the industry changing snap on screw off, snap on snap off, and screw on screw off sport and flat closures for the dairy, beverage, and water industry. These closures can be applied to bottles made from the full spectrum of current industry resins.

Alexion, AstraZeneca Rare Disease, is a global pharmaceutical company dedicated to improving health equity for individuals living with rare diseases. Through innovative research, development, and corporate social responsibility initiatives, they strive to provide life-changing medicines and support services for patients and families facing rare and devastating conditions. Driven by real stories and inspired by individuals like Albie, Ruthie, and Donnan, Alexion, AstraZeneca Rare Disease, is committed to making a meaningful impact in the rare disease community. With a focus on transforming the lives of those affected by rare diseases, they work tirelessly to push the boundaries of medicine and healthcare services to create a better reality for patients worldwide.Generated from the website